D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
$596M |
| 2 |
Accenture
ACN
|
$470M |
| 3 |
Intel
INTC
|
$412M |
| 4 |
Adobe
ADBE
|
$365M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$258M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.5B |
| 2 |
Apple
AAPL
|
$1.02B |
| 3 |
Microsoft
MSFT
|
$776M |
| 4 |
Netflix
NFLX
|
$688M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$542M |
Sector Composition
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
KLA
KLAC
$119B
| $74.9M | 0.07% |
90,858
-24,140
| -21% | -$19.9M |
|
202
Incyte
INCY
$16.9B
| $74.8M | 0.07% |
1,233,217
-152,376
| -11% | -$9.24M |
|
203
Cigna
CI
$81.5B
| $74.6M | 0.07% |
225,725
-321,091
| -59% | -$106M |
|
204
Dollar Tree
DLTR
$20.6B
| $74.6M | 0.07% |
698,731
+13,109
| +2% | +$1.4M |
|
205
Consolidated Edison
ED
$35.4B
| $74.6M | 0.07% |
833,911
-235,915
| -22% | -$21.1M |
|
206
D.R. Horton
DHI
$54.2B
| $72.5M | 0.07% |
514,405
+416,320
| +424% | +$58.7M |
|
207
Snowflake
SNOW
$75.3B
| $68.4M | 0.06% |
506,573
+420,765
| +490% | +$56.8M |
|
208
ConocoPhillips
COP
$116B
| $68.4M | 0.06% |
598,242
+180,843
| +43% | +$20.7M |
|
209
C.H. Robinson
CHRW
$14.9B
| $68.3M | 0.06% |
774,645
+41,057
| +6% | +$3.62M |
|
210
Alnylam Pharmaceuticals
ALNY
$59.2B
| $67.9M | 0.06% |
279,398
+176,011
| +170% | +$42.8M |
|
211
EPAM Systems
EPAM
$9.44B
| $67.8M | 0.06% |
360,550
+247,161
| +218% | +$46.5M |
|
212
BILL Holdings
BILL
$5.24B
| $66.9M | 0.06% |
1,270,772
+495,644
| +64% | +$26.1M |
|
213
AT&T
T
$212B
| $66.3M | 0.06% |
3,469,999
-160,319
| -4% | -$3.06M |
|
214
AutoZone
AZO
$70.6B
| $66M | 0.06% |
22,252
+13,477
| +154% | +$39.9M |
|
215
CVS Health
CVS
$93.6B
| $63.8M | 0.06% |
1,080,291
+980,372
| +981% | +$57.9M |
|
216
Invesco S&P 500 Equal Weight ETF
RSP
$74.1B
| $63.4M | 0.06% |
+385,647
| New | +$63.4M |
|
217
Union Pacific
UNP
$131B
| $63.2M | 0.06% |
279,178
+196,405
| +237% | +$44.4M |
|
218
Boston Scientific
BSX
$159B
| $63M | 0.06% |
818,634
-580,159
| -41% | -$44.7M |
|
219
Parsons
PSN
$8.08B
| $62.4M | 0.06% |
762,163
-116,510
| -13% | -$9.53M |
|
220
ARK Innovation ETF
ARKK
$7.49B
| $62.2M | 0.06% |
1,414,713
+774,315
| +121% | +$34M |
|
221
Capital One
COF
$142B
| $61.9M | 0.06% |
446,828
+113,417
| +34% | +$15.7M |
|
222
ATI
ATI
$10.7B
| $61.9M | 0.06% |
1,115,560
+534,012
| +92% | +$29.6M |
|
223
Clorox
CLX
$15.5B
| $61.8M | 0.06% |
452,755
-171,420
| -27% | -$23.4M |
|
224
Vertiv
VRT
$47.4B
| $61.7M | 0.06% |
712,339
+55,433
| +8% | +$4.8M |
|
225
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.6B
| $61.2M | 0.06% |
335,649
-241,232
| -42% | -$44M |
|